AST SpaceMobile selected Blue Origin's New Glenn together with existing launch vehicles to launch next generation BlueBird ...
Bluebird reports 17 people with sickle cell disease started receiving Lyfgenia gene therapy, with 35 starting Zynteglo for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback